Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tina Susan Nova Insider Profile
4 Followers
Tina Susan Nova, Director at Arena Pharma, holds 0.00 shares in Arena Pharma (Ticker: ARNA), holds 750.00 shares in OpGen (Ticker: OPGN), holds ― shares in Exagen (Ticker: XGN).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+12.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tina Susan Nova holds in companies
Most Profitable Insider Trade
Stock:
Arena Pharma
(ARNA)
(ARNA)
Rating:Informative Sell
Date:Aug 28, 2020 - Aug 28, 2021
Return:+25.50%
The most profitable trade made by Tina Susan Nova
Tina Susan Nova's Trading History
Arena Pharma
Mar 11, 2022
―
Uninformative Sell
―
$0.00
OpGen
Sep 03, 2019
Director
Uninformative Buy
―
$385.50
Exagen
―
Executive Chairperson, Director
―
―
Azenta
Feb 13, 2024
Director
Uninformative Sell
162.52K
$316.68K
Veracyte
Mar 07, 2022
President, CLIA U.S.
Uninformative Buy
―
$1.49M
DMK Pharmaceuticals
Mar 07, 2013
Director
Uninformative Buy
―
$692.16
Heska
―
―
―
$0.00
NanoString Technologies
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Tina Susan Nova's performance on stock
You May Also Like
Tina Susan Nova insider profile FAQ
What is the percentage of profitable transactions made by Tina Susan Nova?
The percentage of profitable transactions made by Tina Susan Nova is 50%.
What is the average return per transaction made by Tina Susan Nova?
The average return per transaction made by Tina Susan Nova is 12.10%.
What stocks does Tina Susan Nova hold?
Tina Susan Nova holds: ARNA, OPGN, XGN, AZTA, VCYT, DMKPQ, HSKA, NSTGQ stocks.
What was Tina Susan Nova’s latest transaction?
Tina Susan Nova latest transaction was an Uninformative Sell of ―.
What was Tina Susan Nova's most profitable transaction?
Tina Susan Nova’s most profitable transaction was an Informative Sell of ARNA stock on August 28, 2020. The return on the trade was 25.50%.
What is Tina Susan Nova's role in Arena Pharma?
Tina Susan Nova's role in Arena Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.